Integer Holdings Corporation ITGR

FY2025 · ended Dec 31, 2025 · Revenue $1.85B, +8.0% YoY · Filed Feb 23, 2026

Integer Holdings Corporation (ITGR) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 billion and net income of $102.8 million. Free cash flow was $105.1 million. As of Oct 2, 2026 it held $14.1 million in cash and investments and $1.3 billion in total debt.

Revenue (TTM)
$1.83B
-0.3% vs year-ago TTM
Net income (TTM)
$103.70M
+19.3% vs year-ago TTM
Operating cash flow (TTM)
$176.48M
-13.5% vs year-ago TTM
Free cash flow (TTM)
$81.82M
-32.6% vs year-ago TTM
EPS (TTM)
$3.00
+23.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
34.41M
+2.3% vs prior year
Net cash
$-1.33B
as of Oct 2, 2026
Operating margin
8.2%
FY 2026

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ITGR (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Plano, TX
SEC filer status
Large accelerated filer
SEC CIK
1114483
Former names
GREATBATCH, INC. (until May 31, 2016); WILSON GREATBATCH TECHNOLOGIES INC (until May 11, 2005)

Other Electromedical & Electrotherapeutic Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$1.9B
$1.7B
$1.6B
$1.3B
$1.2B
Operating income
$221.3M
$208.2M
$163.3M
$112.7M
$135.7M
Net income
$102.8M
$119.9M
$90.7M
$66.4M
$96.8M
Diluted EPS
$2.89
$3.36
$2.69
$1.99
$2.91
Operating cash flow
$196.1M
$205.2M
$180.2M
$116.4M
$156.7M
Free cash flow
$105.1M
$99.8M
$60.3M
$41.7M
$103.2M
Total assets
$3.4B
$3.1B
$2.9B
$2.8B
$2.6B
Total liabilities
$1.7B
$1.5B
$1.4B
$1.4B
$1.2B
Stockholders' equity
$1.7B
$1.6B
$1.5B
$1.4B
$1.4B
Cash and investments
$17.2M
$46.5M
$23.7M
—
—
Total debt
$1.3B
$1.1B
$1.1B
$1.0B
$905.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Oct 2, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Shareholder vote results, Regulation FD disclosure
Oct 21, 2026 Oct 21, 2026
8-K Current report
Other events
Oct 14, 2026 Oct 14, 2026
8-K Current report
Other events
Oct 2, 2026 Oct 2, 2026
8-K Current report
Other events
Sep 30, 2026 Sep 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.